The agency will act without longer safety studies.
The trial results were released Tuesday.
The pharmaceutical maker was announced Friday.
Merck pulled Vioxx from the market.
A study showed it doubled patients risk of heart attacks and strokes.
Its blockbuster arthritis drug Vioxx causes heart problems.
Merck withdrew Vioxx in September after finding.
Health Canada asked Pfizer.
The british journal criticized a we drug company.
Email provided fda spokeswoman Kathleen Quinn.
The medications can increase doctors.
The Vioxx withdrawal presents an opportunity for a pain-relief reality check.
Cox-2 inhibitors carry some cardiovascular risk.
